| Usefulness of Quantification and Serial Monitoring of Fine Crackles for Early Detection of Treatment-related Lung Injury: A Report of Two Cases K Nakamoto, Y Horimasu, K Yamaguchi, S Sakamoto, T Masuda, ... Internal Medicine 63 (12), 1783-1787, 2024 | | 2024 |
| High S100A9 level predicts poor survival, and the S100A9 inhibitor paquinimod is a candidate for treating idiopathic pulmonary fibrosis S Miura, H Iwamoto, M Namba, K Yamaguchi, S Sakamoto, Y Horimasu, ... BMJ Open Respiratory Research 11 (1), e001803, 2024 | | 2024 |
| Hypoxia-inducible factor 1α modulates interstitial pneumonia-mediated lung cancer progression K Shimoji, T Nakashima, T Masuda, M Namba, S Sakamoto, K Yamaguchi, ... Journal of Translational Medicine 21 (1), 857, 2023 | | 2023 |
| Exhaled Nitric Oxide and Olfactory Dysfunction in Patients with Asthma: Association with Chronic Rhinosinusitis T Oda, H Iwamoto, S Takeno, T Kawasumi, K Takemoto, M Nishida, ... Medicina 59 (10), 1776, 2023 | | 2023 |
| Intestinal overgrowth of Candida albicans exacerbates bleomycin‐induced pulmonary fibrosis in mice with dysbiosis T Yamada, T Nakashima, T Masuda, S Sakamoto, K Yamaguchi, ... The Journal of Pathology 261 (2), 227-237, 2023 | 2 | 2023 |
| Nestin and Notch3 collaboratively regulate angiogenesis, collagen production, and endothelial–mesenchymal transition in lung endothelial cells W Daido, T Nakashima, T Masuda, S Sakamoto, K Yamaguchi, ... Cell Communication and Signaling 21 (1), 247, 2023 | | 2023 |
| Clinical characteristics of extrapulmonary nontuberculous mycobacteria infections in comparison with pulmonary infections: A single-center, retrospective study in Japan K Omori, H Kitagawa, K Yamaguchi, S Sakamoto, Y Horimasu, T Masuda, ... Journal of Infection and Chemotherapy 29 (9), 875-881, 2023 | 5 | 2023 |
| Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases T Nakashima, K Omori, M Namba, K Yamaguchi, S Sakamoto, ... Respiratory Medicine 212, 107224, 2023 | 2 | 2023 |
| Predictive value of serum high‐mobility group box 1 levels for checkpoint inhibitor pneumonitis H Tanahashi, K Yamaguchi, K Kurose, S Nakao, S Sakamoto, Y Horimasu, ... Respirology 28 (4), 380-388, 2023 | | 2023 |
| Preserved ratio impaired spirometry with or without restrictive spirometric abnormality S Miura, H Iwamoto, K Omori, K Yamaguchi, S Sakamoto, Y Horimasu, ... Scientific Reports 13 (1), 2988, 2023 | 13 | 2023 |
| Association between Plasminogen Activator Inhibitor-1 and Osimertinib Tolerance in EGFR-Mutated Lung Cancer via Epithelial–Mesenchymal Transition K Tokumo, T Masuda, T Nakashima, M Namba, K Yamaguchi, ... Cancers 15 (4), 1092, 2023 | 1 | 2023 |
| Effect of dupilumab in a patient with severe asthma complicated with recurrent anaphylaxis: a case report H Iwamoto J Investig Allergol Clin Immunol 33 (3), 2023 | 6 | 2023 |
| Prediction model for patient prognosis in idiopathic pulmonary fibrosis using hybrid radiomics analysis D Kawahara, T Masuda, R Nishioka, M Namba, N Imano, K Yamaguchi, ... Research in Diagnostic and Interventional Imaging 4, 100017, 2022 | | 2022 |
| Dupilumab as an adjunct treatment for a patient with steroid-dependent immunoglobulin G4-related disease complicated by asthma: a case report T Otani, H Iwamoto, Y Yoshida, K Yamaguchi, S Sakamoto, Y Horimasu, ... Journal of Asthma 59 (12), 2395-2401, 2022 | 6 | 2022 |
| Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic … S Isoyama, K Yamaguchi, N Imano, S Sakamoto, Y Horimasu, T Masuda, ... International Journal of Clinical Oncology 27 (11), 1698-1705, 2022 | | 2022 |
| Pneumonia and meningoencephalitis due to varicella-zoster virus reinfection and Epstein-Barr virus reactivation in a patient with rheumatoid arthritis N Ito, T Masuda, K Yamaguchi, S Sakamoto, Y Horimasu, T Nakashima, ... Internal Medicine 61 (19), 2961-2965, 2022 | 3 | 2022 |
| Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation K Yamaguchi, H Iwamoto, S Sakamoto, Y Horimasu, T Masuda, ... Respiratory Investigation 60 (4), 531-542, 2022 | 7 | 2022 |
| Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer N Watari, K Yamaguchi, H Terada, K Hamai, K Masuda, Y Nishimura, ... BMC Pulmonary Medicine 22 (1), 260, 2022 | 2 | 2022 |
| Vocal cord dysfunction detected by a three-dimensional image of dynamic change in respiratory resistance in a patient with difficult-to-treat asthma: a case report A Oda, T Otani, H Iwamoto, M Nishida, Y Horibe, K Yamaguchi, ... Journal of Asthma 59 (6), 1157-1161, 2022 | | 2022 |
| Primary pulmonary mucosa-associated lymphoid tissue lymphoma with the high expression of IgG4 H Tanahashi, K Yamaguchi, T Koura, T Kambara, K Yamada, S Sakamoto, ... Internal Medicine 61 (7), 1043-1048, 2022 | 4 | 2022 |
Manabu AbeProfessor of Chemistry, Hiroshima University在 hiroshima-u.ac.jp 的电子邮件经过验证
Manabu AbeProfessor of Chemistry, Hiroshima University在 hiroshima-u.ac.jp 的电子邮件经过验证
Hideyuki OguroUniversity of Connecticut School of Medicine在 uchc.edu 的电子邮件经过验证